NewslettersCell Therapy NewsMesenchymal Cell News Engineered Immunomodulatory Accessory Cells Improve Experimental Allogeneic Islet Transplantation without Immunosuppression By Danielle Corrigan - July 25, 2022 0 Researchers engineered programmed death ligand-1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein–modified mesenchymal stromal cells as accessory cells for islet cotransplantation. [Science Advances] Full Article